Log in to save to my catalogue

GEMMs as preclinical models for testing pancreatic cancer therapies

GEMMs as preclinical models for testing pancreatic cancer therapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5e6bdc5d49834fd9899584727434905b

GEMMs as preclinical models for testing pancreatic cancer therapies

About this item

Full title

GEMMs as preclinical models for testing pancreatic cancer therapies

Publisher

England: The Company of Biologists Ltd

Journal title

Disease models & mechanisms, 2015-10, Vol.8 (10), p.1185-1200

Language

English

Formats

Publication information

Publisher

England: The Company of Biologists Ltd

More information

Scope and Contents

Contents

Pancreatic ductal adenocarcinoma is the most common form of pancreatic tumour, with a very limited survival rate and currently no available disease-modifying treatments. Despite recent advances in the production of genetically engineered mouse models (GEMMs), the development of new therapies for pancreatic cancer is still hampered by a lack of reli...

Alternative Titles

Full title

GEMMs as preclinical models for testing pancreatic cancer therapies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5e6bdc5d49834fd9899584727434905b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5e6bdc5d49834fd9899584727434905b

Other Identifiers

ISSN

1754-8403,1754-8411

E-ISSN

1754-8411,1754-8403

DOI

10.1242/dmm.021055

How to access this item